Fundraising Fox

AOA Dx

YC S21 ↗

Denver, US · Founded 2020 · Delaware corporation · 25 employees · 25 known investors

aoadx.com ↗

AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum. The company serves oncologists and patients in women's health diagnostics.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesHealthcareDiagnosticsWomen's Healthin /aoadx/@AOA_Dxycombinator.com ↗

Founders & leadership· Y Combinator alumni (S21)

OPOriana Papin-Zoghbi
Oriana Papin-Zoghbiin𝕏Founder
AFAlex Fisher
Alex FisherinFounder/COO
AJAnna Jeter
Anna Jeterin𝕏Founder
AM
Abigail McelhinnyExecutive Officer
OZ
Oriana Zoghbi-HarbExecutive Officer, Director
SS
Surbhi SarnaDirector
JF
John FriedmanDirector

Investors · 25

AlleyCorp✓ verifiedNew York · $1M – $5M
Good Growth Capital✓ verifiedCharleston
Joyance Partners✓ verifiedBerlin
Y Combinator✓ verifiedSan Francisco · $500K
AstiaSilicon Valley
Aurum Venture PartnersPleasanton
Bantam GroupWestwood
Beacon AngelsBoston · $50K – $400K
Cancer FundPhoenix
Creative Destruction Lab (CDL)Toronto · $50K – $250K
Emmeline VenturesParadise Valley · $50K – $500K
FemHealth VenturesShort Hills
Foreground CapitalBoston
Kube VC
Launchpad Venture GroupBoston · $8M – $10M
LongeVCWashington D.C.
Olive Tree CapitalBoston
Oxonian VenturesPalo Alto
TBD AngelsNew York
Undeterred CapitalLos Angeles · $500K – $1Mvia Joe Wilson · inferred
VU Venture PartnersSan Francisco · $200K – $1M
Walnut Venture AssociatesWellesley
Alley Robotics VenturesreportedCohasset · $500K – $2Mvia Abe Murray · inferred
Gore Range CapitalreportedSouthlake · $500K – $5M
HelmreportedNew York · $500K

Reported raises · per SEC filings

Form D private placements
▶$8.1MraisedOct 2025 · 40 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Surbhi SarnaDirector
  • Anna Milik JeterExecutive Officer
  • Abigail McelhinnyExecutive Officer
  • Oriana Papin-ZoghbiExecutive Officer, Director
  • John FriedmanDirector
  • Alexander James FisherExecutive Officer
Offering amount
$30.6M
Amount sold
$8.1M
First sale
Oct 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.8MraisedDec 2024 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexander James FisherExecutive Officer
  • Surbhi SarnaDirector
  • Anna Milik JeterExecutive Officer
  • John FriedmanDirector
  • Oriana Papin-ZoghbiExecutive Officer, Director
  • Abigail McelhinnyExecutive Officer
Offering amount
$7.5M
Amount sold
$1.8M
First sale
Dec 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$23.6MraisedJul 2023 · 119 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Surbhi SarnaDirector
  • Anna Milik JeterExecutive Officer
  • Oriana Papin-ZoghbiExecutive Officer, Director
  • John FriedmanDirector
  • Alexander James FisherExecutive Officer
Offering amount
$24.2M
Amount sold
$23.6M
First sale
Jul 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.6MraisedNov 2021 · 33 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Anna Milik JeterExecutive Officer, Director
  • Surbhi SarnaDirector
  • Alexander FisherExecutive Officer, Director
  • Oriana Zoghbi-HarbExecutive Officer, Director
Offering amount
$5M
Amount sold
$2.6M
First sale
Nov 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedJul 2021 · 38 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Anna Milik JeterExecutive Officer, Director
  • Alexander James FisherExecutive Officer, Director
  • Oriana Zoghbi-HarbExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$2.5M
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news